Abstract
Viruses that infect bacteria are emerging as attractive biocontrol agents and biopreservatives for foods. Since these bacteriophages kill the target pathogens by lysis and are also consumed along with food, it is essential to evaluate their collateral toxicity on the probiotic gut microbiota. In this study, we examined the acute oral toxicity of a Salmonella phage isolated from sewage in mice. Acute oral administration of the Salmonella phage for five consecutive days did not show any significant pathological changes in the vital organs like lung, kidneys, heart, liver, and intestine. In addition, growth of typical probiotic microbiota remained unaffected even after incubation up to 24 h with the Salmonella phage. The results of this study clearly showed that oral administration of the lytic Salmonella phage did not have any significant adverse effects on the animals, may not harm the probiotic gut microbiota, and are likely to be safe for use in food preservation.
Similar content being viewed by others
Data Availability
The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
EFSA-European Food Safety Authority (2020) Salmonella the most common cause of foodborne outbreaks in the European Union. https://www.efsa.europa.eu/en/news/Salmonella-most-common-cause-foodborne-outbreaks-european-union. Accessed 12 Dec 2019
Hungaro HM, Mendonca RCS, Gouvea DM, Vanetti MCD, Pinto CLO (2013) Use of bacteriophages to reduce salmonella in chicken skin in comparision with chemical agents. Food Res Int 52:75–81
Mahony J, McAuliffe O, Ross RP, Sinderen DV (2011) Bacteriophages as biocontrol agents of food pathogens. Curr Opin Biotechnol 22:157–163
Mills S, Shanahan F, Stanton C, Hill C, Coffey A, Ross RP (2013) Influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4:4–16
Collins SM, Denou E, Verdu EF, Bercik P (2009) The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 41:850–853. https://doi.org/10.1016/j.dld.2009.07.023
Reiff C, Kelly D (2010) Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol 300:25–33. https://doi.org/10.1016/j.ijmm.2009.08.004
Kumar RN, Bhima B, Kumar PU, Ghosh S (2020) Bio-control of Salmonella Spp. In carrot salad and raw chicken skin using lytic bacteriophages. LWT Food Sci Technol 122:109039
Carey-Smith GV, Billington C, Cornelius AJ, Hudson JA, Heinemann JA (2006) Isolation and characterization of bacteriophages infecting Salmonella spp. FEMS Microbiol Lett 258:182–6
Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Jhonson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 501:69–76
Tong M, Jacobes JP, McHardy IH, Braun J (2003) Sampling of intestinal microbiota and targeted amplification of bacterial 16S rRNA genes for microbial ecologic analysis. Curr Protoc Immunol 107(1):7–41
Panghal A, Yadav DN, Khatkar BS, Sharma H, Kumar V, Chhikara N (2018) Post-harvest malpractices in fresh fruits and vegetables: food safety and health issues in India. Nutr Food Sci. https://doi.org/10.1108/NFS-09-2017-0181
Singh VP (2018) Recent approaches in food bio-preservation—a review. Op Vet J 8:104–111
Petsong K,Vongkamja (2015) Applications of Salmonella bacteriophages in the food production chain. In: the battle against microbial pathogens: basic science, Technol Adv and Edu Prog 275–283. https://www.semanticscholar.org/paper/Applications-of-Salmonella-bacteriophages-in-the-Petsong-Vongkamjan/49fc6715c6a0e86eca7b7c341c5445d5b5e296cd. Accessed 23 Nov 2021
FDA-Food and Drug Administration (2012) Intralytix GRAS notification. https://www.fda.gov/media/133519/download. Accessed 23 Nov 2021
Kutateladze M, Adamia R (2010) Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 28:591–595
Fernebro J (2011) Fighting bacterial infections—future treatment options. Drug Resist Updat 14:125–139
Hagens S, Offerhaus ML (2008) Bacteriophages—new weapons for food safety. Food Technol 62:46–54
Ventura M, Turroni F, Lima-Mendez G, Foroni E, Zomer A, Duranti S, Giubellini V, Bottacini F, Horvath P, Barrangou R, Sela DA, Mills DA, Sinderen D (2005) Comparative analyses of prophage-like elements present in bifidobacterial genomes. Appl Environ Microbiol 75:6929–6936
Ventura M, Turroni F, Canchaya C, Vaughan EE, O’Toole PW, Sinderen D (2009) Microbial diversity in the human intestine and novel insights from metagenomics. Front Biosci 14:3214–3221
Sozzi T (2006) A method for preventing the inactivation, due to specific bacteriophages, of probiotic strain mixtures used in cattle-breeding. Patent WO2006/134579A2
Angly FE, Felts B, Breitbart M, Salamon P, Edwards RA, Carlson C, Chan AM, Haynes M, Kelley S, Liu H, Mahaffy JM, Mueller JE, Nulton J, Olson R, Parsons R, Rayhawk S, Suttle CA, Rohwer F (2006) The marine viromes of four oceanic regions. PLOS Biol 4:368
Parada V, Baudoux AC, Sintes E, Weinbauer MG, Herndl GJ (2008) Dynamics and diversity of newly produced virioplankton in the North Sea. ISME J 2:924–936
Golomidova A, Kulikov E, Isaeva A, Manykin A, Letarov A (2007) The diversity of coliphages and coliforms in horse feces reveals a complex pattern of ecological interactions. Appl Environ Microbiol 73:5975–5981
Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S, Brussow H (2004) In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 48:2558–2569
Kang H, Kim J, Jung T, Woo G (2013) wksl3, a new biocontrol agent for salmonella enterica serovars enteritidis and typhimurium in foods: characterization, application, sequence analysis, and oral acute toxicity study. Appl Environ Microbiol 79(6):1956–1968
Wójcik EA, Stanczyk M, Wojtasik A, Kowalska JD, Nowakowska M, Łukasiak M, Bartnicka M, Kazimierczak J, Dastych J (2020) Comprehensive evaluation of the safety and efficacy of bafasal®bacteriophage preparation for the reduction of salmonella in the food chain. Viruses 12(7):742
Bruttin A, Brussow H (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Appl Environ Microbiol 49(7):2874–2878
Acknowledgements
The authors acknowledge the encouragement given during study by the Director, National Institute of Nutrition, Indian Council of Medical Research (ICMR), Hyderabad, India, and Director General, Indian Council of Medical Research (ICMR), New Delhi, India
Funding
Fund for this study was obtained from the National Institute of Nutrition, Indian Council of Medical Research (ICMR), Hyderabad, India.
Author information
Authors and Affiliations
Contributions
Conceptualization, investigation, and methodology: RNK; observation of histopathology slides: MVS; editing and validation: BR; project administration: PUK; writing original draft and data curation: KP; resources and supervision: HR; visualization: BB; formal analysis: HN; animal experiment: MS; preparation of histopathological slides: KS; writing, review, and editing: SG.
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declare no competing interests.
Ethical Approval
IAEC (Institutional Animal Ethical Committee) of NIN (National Institute of Nutrition) permission was obtained before initiating this experiment (Ref No. ICMR-NIN/IAEC/01/012/2020).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, R.N., Surekha, M.V., Ramalingam, B. et al. Oral Toxicity Study for Salmonella Killing Lytic Bacteriophage NINP13076 in BALB/c Mice and Its Effect on Probiotic Microbiota. Curr Microbiol 79, 89 (2022). https://doi.org/10.1007/s00284-021-02754-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00284-021-02754-9